PSN Research

@psnresearch

PSNRESEARCH is a full-service global Contract Research Organization (CRO) with over 400 employees in 10 offices across Northern America and Europe.

Vrijeme pridruživanja: svibanj 2014.
Rođen/a 1997.

Tweetovi

Blokirali ste korisnika/cu @psnresearch

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @psnresearch

  1. 10. lip 2019.

    Sermes CRO a PSN Research Company, has been awarded as the most Innovative Company Global Supplier 2019 by MSD global

    Poništi
  2. 6. velj 2019.
    Poništi
  3. proslijedio/la je Tweet
    9. pro 2018.

    We thank Italfarmaco & Martindale Pharma Mitsubishi Tanabe Pharma Europe @MRPHarmaUS and Glasgow Convention Bureau for their support and for hosting the 29th !

    Poništi
  4. 10. sij 2019.

    FDA launches new office to rethink how drugs are reviewed

    Poništi
  5. proslijedio/la je Tweet
    22. kol 2018.
    Poništi
  6. proslijedio/la je Tweet
    23. kol 2018.
    Poništi
  7. proslijedio/la je Tweet
    24. kol 2018.

    Blood cancers don't just give up, so neither do we. CAR-T cell therapy could cure cancer where there are very little treatment options

    Poništi
  8. 1. kol 2018.

    Do you know what happenned with the EMA´s Communication Perception Survey 2017??? See the results and Report

    Poništi
  9. 1. kol 2018.

    EMA’s publication of clinical data a success

    Poništi
  10. 1. kol 2018.

    How the EU Agencies contribute to the lives of everyone in Europe???

    Poništi
  11. proslijedio/la je Tweet
    30. srp 2018.

    La OMS publica su nueva Clasificación Internacional de Enfermedades (CIE-11)

    Poništi
  12. proslijedio/la je Tweet
    5. srp 2018.

    and continue their collaboration at a meeting on 5 July. Topics covered include , labelling, and registries:

    Poništi
  13. 3. srp 2018.

    Lymph node fibrosis: a structural barrier to unleashing effective vaccine immunity

    Poništi
  14. 3. srp 2018.

    Statement from FDA Commissioner, on agency’s continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug

    Poništi
  15. 3. srp 2018.

    First two CAR-T cell medicines recommended for approval in the European Union

    Poništi
  16. proslijedio/la je Tweet
    3. srp 2018.
    Poništi
  17. proslijedio/la je Tweet
    27. lip 2018.

    carried out a total of 925 activities involving and 445 activities involving during 2017. Read more in our latest Stakeholder Engagement report:

    Poništi
  18. proslijedio/la je Tweet
    2. srp 2018.

    and will be at the held 4-6 July in with the poster "EVALUATION OF THE IMPACT OF TERMINATING THE REIMBURSEMENT OF A THERAPEUTIC CLASS OF DRUGS ON THE FRENCH HEALTH SYSTEM". Join Karine Mari and Rafael Zurita to discuss your European studies.

    Poništi
  19. proslijedio/la je Tweet
    22. ožu 2018.

    Are you a patient, family member or carer? Help us understand your views on the sharing and protection of your health data! Respond to a survey by 31 March to share your views (survey available in 23 languages!):

    Poništi
  20. proslijedio/la je Tweet
    23. ožu 2018.

    recommends 6 for approval at its March 2018 meeting

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·